SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, and in continuation of earlier notice dated 26th September, 2018, Ind-Swift has informed that in the VAT matter of 926 companies/cases being investigated by the VAT Tribunal which was referred for the legal enquiry ; the company was already co-operating with the investigating agency. The agency has however now summoned company’s Director viz. N.R.Munjal for investigation. N.R.Munjal has joined the investigation.

The above information is a part of company’s filings submitted to BSE.

Ind-Swift - Amalgama Share Price

15.70 0.00 (0.00%)
13-Aug-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1829.90
Dr. Reddys Lab 1308.00
Cipla 1371.30
Zydus Lifesciences 939.15
Lupin 2467.00
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×